- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07284095
Nutritional Intervention With Tenebrio Molitor Powder in Children With Chronic Malnutrition in the Democratic Republic of the Congo (SANTE)
SANTE INITIATIVE: Nutritional Intervention With Tenebrio Molitor Powder in Children With Chronic Malnutrition in the Democratic Republic of the Congo
The goal of this clinical trial is to evaluate whether a dietary supplement based on Tenebrio molitor (mealworm flour) can improve nutritional status and biomarkers of micronutrient deficiency in children aged 2-10 years.
The main questions it aims to answer are:
• Does regular supplementation with Tenebrio molitor flour improve chronic malnutrition status
Researchers will compare the intervention group (children receiving Tenebrio molitor flour supplement) with the control group (children receiving a traditional maize-soy flour supplement) to assess differences in biochemical and anthropometric outcomes after the intervention period.
Participants will:
- Participate in baseline and follow-up anthropometric and blood sample assessments (hemoglobin, albumin, zinc, iron, calcium, magnesium, vitamin A, folic acid, vitamin B12, prealbumin).
- Consume a daily dietary supplement (either Tenebrio molitor flour or maize-soy flour) for the duration of the intervention.
- Provide information on dietary intake and general health status through structured questionnaires administered by the research team.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Nerea Martín Calvo, PhD
- Phone Number: +34 629 34 79 56
- Email: nmartincalvo@unav.es
Study Contact Backup
- Name: Andrea Aquino Blanco, Nutritionist
- Phone Number: +34 692468366
- Email: nmartincalvo@unav.es
Study Locations
-
-
-
Bukavu, Democratic Republic of the Congo
- Kesho Congo
-
Contact:
- Adolphe Nyakasane, Pediatritian
- Phone Number: +243 820 422 427
- Email: adolphe.nyakasane@keshocongo.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children diagnosed with chronic malnutrition (weight-for-height or BMI below -2 SD according to WHO standards).
Children whose families agree to participate in the intervention and sign the informed consent form.
Exclusion Criteria:
- Children with severe acute illnesses that may interfere with the intervention.
- Children with known allergies to the ingredients of the nutritional products provided.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
Participants will receive a daily supplement made from Tenebrio molitor (mealworm) flour for 24 weeks.
|
The intervention consists of a daily dietary supplement made from Tenebrio molito powder, a sustainable and high-protein insect. Each participant in the intervention group will receive a pre-measured daily dose of Tenebrio molitor The supplement is designed to improve protein quality and micronutrient intake, particularly iron, zinc, and vitamin B12, in children aged 2-10 years. This intervention differs from traditional nutritional supplements by using Tenebrio molitor as a novel source of animal protein and micronutrients, contributing to sustainable food systems and child nutrition in low-resource settings. |
|
Active Comparator: Control Group
Participants will receive a daily supplement made from maize and soy flour for 24 weeks.
|
The control supplement is a daily dietary mixture made from maize and soy flour, formulated to match the dose of the intervention supplement but without Tenebrio molitor protein. This preparation represents a conventional plant-based dietary supplement commonly used in nutritional support programs. It serves as an active comparator to assess the added nutritional and functional benefits of Tenebrio molitor flour in improving biochemical and anthropometric indicators of child nutrition. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prealbumin
Time Frame: Baseline (Week 0) and 24 weeks of supplementation.
|
Prealbumin levels will be measured to assess improvement in protein nutritional status among participants receiving Tenebrio molitor flour supplement compared with those receiving maize-soy flour supplement.
|
Baseline (Week 0) and 24 weeks of supplementation.
|
|
Height-for-Age z-scores (WHO Child Growth Standards)
Time Frame: Baseline, 12 weeks and 24 weeks
|
To evaluate the effect of Tenebrio molitor supplementation on growth parameters in children.
Scale range: z-scores less than or equal to -2 indicate stunting; less than or equal to -3 indicate severe stunting.
Values close to 0 reflect adequate growth.
High positive values (>+2 or >+3) indicate heights that are significantly above the average
|
Baseline, 12 weeks and 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Serum Iron Concentration (µg/dL)
Time Frame: From Baseline to 24 Weeks
|
To determine whether Tenebrio molitor flour improves serum iron levels compared to maize-soy flour.
|
From Baseline to 24 Weeks
|
|
Change in Serum Zinc Concentration (µg/dL)
Time Frame: From Baseline to 24 Weeks
|
To determine whether Tenebrio molitor flour improves serum Zinc levels compared to maize-soy flour.
|
From Baseline to 24 Weeks
|
|
Change in Serum Vitamin B12 Concentration (pg/mL)
Time Frame: From Baseline to 24 Weeks
|
To determine whether Tenebrio molitor flour improves serum Vitamin B12 levels compared to maize-soy flour.
|
From Baseline to 24 Weeks
|
|
Change in Serum Vitamin B9 (Folate) Concentration (µg/dL)
Time Frame: From Baseline to 24 Weeks
|
To determine whether Tenebrio molitor flour improves serum Vitamin B9 (Folate) levels compared to maize-soy flour.
|
From Baseline to 24 Weeks
|
|
Change in Serum Vitamin A Concentration (µg/dL)
Time Frame: From Baseline to 24 Weeks
|
To determine whether Tenebrio molitor flour improves serum Vitamin A levels compared to maize-soy flour.
|
From Baseline to 24 Weeks
|
|
Change in Serum Calcium Concentration (mg/dL)
Time Frame: From Baseline to 24 Weeks
|
To determine whether Tenebrio molitor flour improves serum Calcium levels compared to maize-soy flour.
|
From Baseline to 24 Weeks
|
|
Change in Serum Magnesium Concentration (mg/dL)
Time Frame: From Baseline to 24 Weeks
|
To determine whether Tenebrio molitor flour improves serum Magnesium levels compared to maize-soy flour.
|
From Baseline to 24 Weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Nerea Martín Calvo, University of Navarra
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SANTE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stunting of Growth
-
University of North Carolina, Chapel HillUniversity of California, Davis; Bill and Melinda Gates Foundation; Kinshasa...CompletedMalnutrition | Stunting of GrowthCongo
-
Günther FinkActive, not recruitingMalnourished Children | Stunting of GrowthZambia
-
University of CopenhagenUniversity of Aarhus; Arla FoodsCompletedGrowth Acceleration | Growth; Stunting, NutritionalDenmark
-
Indonesia UniversityWyeth nutrition indonesiaCompletedGrowth; Stunting, NutritionalIndonesia
-
Danone Asia Pacific Holdings Pte, Ltd.KK Women's and Children's HospitalCompletedGrowth; Stunting, NutritionalSingapore
-
Swiss Federal Institute of TechnologyBRAC University; HarvestPlusCompletedZinc Deficiency | Growth; Stunting, NutritionalSwitzerland, Bangladesh
-
Andalas UniversityIndonesia UniversityCompletedGastrointestinal Microbiome | Growth; Stunting, Nutritional | Immunoglobulin AIndonesia
-
Danone Asia Pacific Holdings Pte, Ltd.KK Women's and Children's HospitalCompletedGrowth; Stunting, NutritionalSingapore
-
University of WashingtonFrankel Family Foundation; Stewardship FoundationActive, not recruitingBreastfeeding, Exclusive | Immunization; Infection | Growth; Stunting, NutritionalEthiopia
-
Washington University School of MedicineKamuzu University of Health Sciences; Project Peanut Butter, MalawiCompletedNutritional StuntingMalawi
Clinical Trials on Tenebrio Molitor powder
-
Swiss Federal Institute of TechnologyZurich University of Applied SciencesCompleted
-
Aimmune Therapeutics, Inc.TerminatedHen Egg AllergyUnited States
-
Mukuba UniversityUniversity of Stellenbosch; Medical Research Council, South AfricaCompleted
-
Children's Hospital of Fudan UniversityTerminated
-
Midwest Center for Metabolic and Cardiovascular...The Hershey CompanyCompletedAmino Acids | Appetite | Gastrointestinal TolerabilityUnited States
-
RiboCor, Inc.Completed
-
University of ManitobaActive, not recruitingHypertension | AlertnessCanada
-
University of California, BerkeleyUniversity of California, DavisCompletedConsumption | Side Effect | AcceptabilityUnited States
-
Burapha UniversityFaculty of Allied Health SciencesRecruitingCalamansi Powder Capsule SupplementationThailand
-
University of Missouri-ColumbiaCalifornia Table Grape CommissionRecruitingObesity &Amp; OverweightUnited States